Methods for the analysis of fluoroquinolones in biological fluids

Bioanalysis

Volumn 1, Issue 2, 2009, Pages 415-435

  Schneider, Marilyn J ^a  

^a EASTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANALYSIS; BLOOD; BODY FLUID; CHEMISTRY; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LUMINESCENCE; MASS SPECTROMETRY; REVIEW; URINE;

ANALYTIC SAMPLE PREPARATION METHODS; ANTI-BACTERIAL AGENTS; BODY FLUIDS; CHROMATOGRAPHY, LIQUID; FLUOROQUINOLONES; HUMANS; LIMIT OF DETECTION; LUMINESCENCE; MASS SPECTROMETRY;

EID: 77953020917     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.37     Document Type: Review

References (155)

1. Carlucci G. Analysis of fuoroquinolones in biological fuids by high-performance liquid chromatography. J. Chromatogr. A 812, 343-367 (1998).
2. Belal F, Al-Majed AA, Al-Obaid AM. Methods of analysis of 4-quinolone antibacterials. Talanta 50, 765-786 (1999).
3. Samanidou VF, Christodoulou EA, Papadoyannis IN. Recent advances used for the determination of fuoroquinolones in pharmaceuticals and samples of biological origin- A review article. Curr. Pharm. Anal. 1, 155-193 (2005).
4. Samanidou VF, Christodoulou EA, Papadoyannis IN. Advances in chromatographic analyses of fuoroquinolones in pharmaceuticals and biological samples- A review article. Curr. Pharm. Anal. 1, 283-308 (2005).
5. Gomez V, Callao MP. Analytical applications of second-order calibration methods. Anal. Chim. Acta 627, 169-183 (2008).
6. Kaur K, Kumar A, Malik AK, Singh B, Rao ALJ. Spectrophotometric methods for the determination of fuoroquinolones: a review. Crit. Rev. Anal. Chem. 38, 2-18 (2008).
7. Rizk M, Belal F, Ibrahim F, Ahmed S, Sheribah ZA. Derivative spectrophotometric analysis of 4-quinolone antibacterials in formulations and spiked biological fuids by their Cu (II) complexes. J. AOAC Int. 84, 368-375 (2001).
8. Amin AS, Moustafa ME, El-Dosoky RMS. Spectrophotometric determination of some fuoroquinolone derivatives in dosage forms and biological fuids using ion-pair complex formation. Anal. Lett. 41, 837-852 (2008).
9. El-Brashy AM, Metwally MES, El-Sepai FA. Spectrophotometric determination of some fuoroquinolone antibacterials by binary complex formation with xanthenes dyes. Il Farmaco 59, 809-817 (2004).
10. El-Kommos ME, Saleh GA, El-Gizawi SM, Abou-Elwafa MA. Spectrofuorometric determination of certain quinolone antibacterials using metal chelation. Talanta 60, 1033-1050 (2003).
11. Salem H, Fada L, Khater W. Spectrofuorimetric determination of certain fuoroquinolones through charge transfer complex formation. Am. J. Pharmacol. Toxicol. 2, 18-25 (2007).
12. Espinosa-Mansilla A, Muñoz de la Peña A, Cañada- Cañada F, González Gómez D. Determinations of fuoroquinolones and nonsteroidal anti-infammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofuorimetry using multivariate calibration. Anal. Biochem. 347, 275-286 (2005).
13. Navalón A, Ballesteros O, Blanc R, Vilchez JL. Determination of ciprofoxacin in human urine and serum samples by solid-phase spectrofuorimetry. Talanta 52, 845-852 (2000).
14. Shtykov SN, Smirnova TD, Bylinkin YG, Kalashnikova N V, Zhemerichkin DA. Determination of ciprofoxacin and enrofoxacin by the sensitized fuorescence of europium in the presence of the second ligand and micelles of anionic surfactants. J. Anal. Chem. 62, 136-140 (2007).
15. Sun HW, Li LQ, Chen XY. Flow injection enhanced chemiluminescence method for determination of ciprofoxacin in pharmaceutical preparations and biological fuids. Anal. Bioanal. Chem. 384, 1314-1319 (2006).
16. Zhuoyong Z, Xia L, Xiaoli W, Shilu C, Baohua S, Huichun Z. Determination of ciprofoxacin by fow injection analysis based on chemiluminescence system. J. Rare Earths 24, 285-288 (2006).
17. Lian N, Zhao H, Sun C, Chen S, Lu Y, Jin L. A study on terbium sensitized chemiluminescence of ciprofoxacin and its application. Microchem. J. 74, 223-230 (2003).
18. +2-Ce(IV) system. Talanta 53, 885-893 (2001).
19. Rodriguez-Diaz RC, Aguilar-Caballos MP, Gómez-Hens A. Simultaneous determination of ciprofoxacin and tetracycline in biological fuids based on dual-lanthanide sensitised luminescence using dry reagent chemical technology. Anal. Chim. Acta 494, 55-62 (2003).
20. Beltyukova S, Teslyuk O, Egorova A, Tselik E. Solid-phase luminescence determination of ciprofoxacin and norfoxacin in biological fuids. J. Fluorescence 12, 269-272 (2002).
21. Torriero AAJ, Salinas E, Raba J, Silber JJ. Sensitive determination of ciprofoxacin and norfoxacin in biological fuids using an enzymatic rotating biosensor. Biosens. Bioelectron. 22, 109-115 (2006).
22. Vilchez JL, Araujo L, Prieto A, Navalón A. Determination of ciprofoxacin and enoxacin in human serum samples by micellar liquid chromatography. Anal. Chim. Acta 516, 135-140 (2004).
23. Manceau J, Gicquel M, Laurentie M, Sanders P. Simultaneous determination of enrofoxacin and ciprofoxacin in animal biological fuids by high-performance liquid chromatography. Application in pharmacokinetic studies in pig and rabbit. J. Chromatogr. B 726, 175-184 (1999).
24. Wu SS, Chein CY, Wen YH. Analysis of ciprofoxacin by a simple high-performance liquid chromatography method. J. Chromatographic Sci. 46, 490-495 (2008).
25. Espinosa-Mansilla A, Muñoz de la Peña A, Gonzalez Gomez, D, Cañada-Cañada F. HPLC determination of ciprofoxacin, cloxacillin, and ibuprofen drugs in human urine samples. J. Sep. Sci. 29, 1969-1976 (2006).
26. Sun H, Qiao F, Liu G, Liang S. Simultaneous isolation of six fuoroquinolones in serum samples by selective molecularly imprinted matrix solid-phase dispersion. Anal. Chim. Acta 625, 154-159 (2008).
27. Da Silva RG, Reyes FGR, Sartori JR, Rath S. Enrofoxacin assay validation and pharmacokinetics following a single oral dose in chickens. J. Vet. Pharmacol Therap. 29, 365-372 (2006).
28. Peyrou M, Bousquet-Melou A, Laroute V, Vrins A, Doucet MY. Enrofoxacin and marbofoxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate frst-pass effect and absorbed fraction. J. Vet. Pharmacol. Therap. 29, 337-344 (2006).
29. Maya MT, Goncalves NJ, Silva NB, Morais JA. Simple high-performance liquid chromatographic assay for the determination of ciprofoxacin in human plasma with ultraviolet detection. J. Chromatogr. B 755, 305-309 (2001).
30. Kamberi M, Tsutsumi K, Kotegawa T, Nakamura K, Nakano S. Determination of ciprofoxacin in plasma and urine by HPLC with ultraviolet detection. Clin. Chem. 44, 1251-1255 (1998).
31. Nemutlu E, Kir S, Ozyuncu O, Beksac MS. Simultaneous separation and determination of seven quinolones using HPLC. Analysis of levofoxacin and moxifoxacin in plasma and amniotic fuid. Chromatographia 66, S15-S24 (2007).
32. Samanidou VF, Demetriou CE, Papadoyannis IN. Direct determination of four fuoroquinolones, enoxacin, norfoxacin, ofoxacin, and ciprofoxacin, in pharmaceuticals and blood serum by HPLC. Anal. Bioanal. Chem. 375, 623-629 (2003).
33. Pellegrino RM, Segoloni F, Cagini C. Simultaneous determination of ciprofoxacin and the active metabolite of prulifoxacin in aqueous humor by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 47, 567-574 (2008).
34. Samanidou VF, Christodoulou EA, Papadoyannis IN. Direct determination of fve fuoroquinolones in chicken whole blood and in veterinary drugs by HPLC. J. Sep. Sci. 28, 325-331 (2005).
35. Yan H, Row, KH, Yang G. Water-compatible molecularly imprinted polymers for selective extraction of ciprofoxacin from human urine. Talanta 75, 227-232 (2008).
36. Zotou A, Miltiadou N. Sensitive LC determination of ciprofoxacin in pharmaceutical preparations and biological fuids with fuorescence detection. J. Pharm. Biomed. Anal. 28, 559-568 (2002).
37. Damiani PC, Nepote AJ, Bearzotti M, Olivieri AC. A test feld for the second-order advantage in bilinear least-squares and parallel factor analyses: fuorescence determination of ciprofoxacin in human urine. Anal. Chem. 76, 2798-2806 (2004).
38. Guo L, Xie Z, Lin X et al. Pharmacokinetics of ciprofoxacin in eels by high-performance liquid chromatography with fuorescence detection. Anal. Biochem. 341, 275-279 (2005).
39. Imre S, Dogaru MT, Vari CE, Muntean T, Kelemen L. Validation of an HPLC method for the determination of ciprofoxacin in human plasma. J. Pharm. Biomed. Anal. 33, 125-130 (2003).
40. Bardot S, Vest P, Renard C, Renaudeau C. Dosage de la ciprofoxacine en milieu serique par chromatographie liquide haute performance. Ann. Biol. Clin. 63, 513-516 (2005).
41. Vybiralova Z, Nobilis M, Zoulova J, Kvetina J, Petr P. High-performance liquid chromatographic determination of ciprofoxacin in plasma samples. J. Pharm. Biomed. Anal. 37, 851-858 (2005).
42. Neckel U, Joukhadar C, Frossard M, Jager W, Muller M, Mayer BX. Simultaneous determination of levofoxacin and ciprofoxacin in microdialysates and plasma by high-performance liquid chromatography. Anal. Chim. Acta 463, 199-206 (2002).
43. Fu LX, Jiang ZG, Ding HZ, Liu YH. Population pharmacokinetics of enrofoxacin and its active metabolite ciprofoxacin in ill cows. J. Vet. Pharmacol. Therap. 31, 240-245 (2008).
44. Garcia MA, Solans C, Aramayona JJ, Rueda S, Bregante MA, de Jong A. SImultaneous determination of enrofoxacin and its primary metabolite, ciprofoxacin, in plasma by HPLC with fuorescence detection. Biomed. Chromatogr. 13, 350-353 (1999).
45. González C, Moreno L, Small J, Jones DG, Bruni SFS. A liquid chromatographic method, with fuorometric detection, for the determination of enrofoxacin and ciprofoxacin in plasma and endometrial tissues of mares. Anal. Chim. Acta 560, 227-234 (2006).
46. Idowu OR, Peggins JO. Simple, rapid determination of enrofoxacin and ciprofoxacin in bovine milk and plasma by high-performance liquid chromatography with fuorescence detection. J. Pharm. Biomed. Anal. 35, 143-153 (2004).
47. Posyniak A, Zmudski J, Niedzielska J. Liquid chromatography analysis of enrofoxacin and ciprofoxacin in chicken blood spotted on flter-paper disks. J. Chromatogr. B 780, 309-314 (2002).
48. Frazier DL, Thompson L, Trettien A, Evans EI. Comparison of the fuoroquinolone pharmacokinetic parameters after treatment with marbofoxacin, enrofoxacin and difoxacin in dogs. J. Vet. Pharmacol. Therap. 23, 293-302 (2000).
49. Espinosa-Mansilla A, Muñoz de la Pena A, González Gomez D, Salinas F. HPLC determination of enoxacin, ciprofoxacin, norfoxacin and ofoxacin with photoinduced fuorimetric (PIF) detection and multiemission scanning. Application to urine and serum. J. Chromatogr. B 822, 185-193 (2005).
50. Holtzapple CK, Buckley SA, Stanker LH. Determination of fuoroquinolones in serum using an on-line clean-up column coupled to high-performance immunoaffnity reverse-phase liquid chromatography. J. Chromatogr. B 754, 1-9 (2001).
51. Zupancic T, Pihlar B. Optimisation of a dialytic set-up for liquid chromatography: automated separation and preconcentration of ciprofoxacin. J. Chromatogr. A 975, 199-209 (2002).
52. Sowinski KM, Kays MB. Determination of ciprofoxacin concentrations in human serum and urine by HPLC with ultraviolet and fuorescence detection. J. Clin. Pharm. Ther. 29, 381-387 (2004).
53. Espinosa-Mansilla A, Muñoz de la Peña A, González Gomez D, Salinas López F. Determination of fuoroquinolones in urine and serum by using high performance liquid chromatography and multiemission scan fuorimetric detection. Talanta 68, 1215-1221 (2006).
54. Garces A, Zerzanova A, Kucera R, Barron D, Barbosa J. Determination of a series of quinolones in pig plasma using solid-phase extraction and liquid chromatography coupled with mass spectrometric detection. Application to pharmacokinetic studies. J. Chromatogr. A 1137, 22-29 (2006).
55. Ballesteros O, Toro I, Sanz-Nebot V, Navalón A, Vilchez JL, Barbosa J. Determination of fuoroquinolones in human urine by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry. J. Chromatogr. B 798, 137-144 (2003).
56. n. J. AOAC Int. 90, 1716-1723 (2007).
57. Wei S, Lin J, Li H, Lin JM. Separation of seven fuoroquinolones by microemulsion electrokinetic chromatography and application to ciprofoxacin, lomefoxacin determination in urine. J. Chromatogr. A 1163, 333-336 (2007).
58. Perez-Ruiz T, Martínez-Lozano C, Sanz A, Bravo E. Separation and simultaneous determination of quinolone antibiotics by capillary zone electrophoresis. Chromatographia 49, 419-423 (1999).
59. Hernández M, Borrull F, Calull M. Determination of quinolones in plasma samples by capillary electrophoresis using solid-phase extraction. J. Chromatogr. B 742, 255-265 (2000).
60. Hernández M, Aguilar C, Borrull F, Calull M. Determination of ciprofoxacin, enrofoxacin and fumequine in pig plasma samples by capllary isotachophoresis-capillary zone electrophoresis. J. Chromatogr B 772, 163-172 (2002).
61. Ferdig M, Kaleta A, Vo TDT, Buchberger W. Improved capillary electrophoretic separation of nine (fuoro)quinolones with fuorescence detection for biological and environmental samples. J. Chromatogr. A 1047, 305-311 (2004).
62. Liu YM, Jia YX, Tian W. Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection. J. Sep. Sci. 31, 3765-3771 (2008).
63. Feng YL, Dong C. Simultaneous determination of trace ofoxacin, ciprofoxacin, and sparfoxacin by micelle TLC-fuorimetry. J. Chromatogr. Sci. 42, 474-477 (2004).
64. Wang PL, Chen L, Fan YF. Selective separation and simultaneous determination of trace levels of fve types of fuorinated quinolone drugs by thin-layer chromatography/fuorescence densitometry. J. AOAC Int. 84, 684-688 (2001).
65. Rizk M, Belal F, Ibrahim F, Ahmed S, El-Enany N. Spectrofuorimetric analysis of certain 4-quinolones in pharmaceuticals and biological fuids. Pharm. Acta Helv. 74, 371-377 (2000).
66. Ballesteros O, Vilchez JL, Taoufki J, Navalon A. Determination of the antibacterial drug enrofoxacin by solid-phase spectrofuorimetry. Microchim. Acta 148, 227-233 (2004).
67. Navalón A, Blanc R, Reyes L, Navas N, Vilchez JL. Determination of the antibacterial enrofoxacin by differential-pulse adsorptive stripping voltammetry. Anal. Chim. Acta 454, 83-91 (2002).
68. Rizk M, Belal F, Ibrahim F, Ahmed S, El-Enany NM. Voltammetric analysis of certain 4-quinolones in pharmaceuticals and biological fuids. J. Pharm. Biomed. Anal. 24, 211-218 (2000).
69. Caro E, Marce RM, Cormack PAG, Sherrington DC, Borrull F. Novel enrofoxacin imprinted polymer applied to the solid-phase extraction of fuorinated quinolones from urine and tissue samples. Anal. Chim. Acta 562, 145-151 (2006).
70. Cañada-Cañada F, Espinosa-Mansilla A, Muñoz de la Peña A. Separation of ffteen quinolones by high performance liquid chromatography: application to pharmaceuticals and ofoxacin determination in urine. J. Sep. Sci. 30, 1242-1249 (2007).
71. Holtzapple CK, Pishko J, Stanker LH. Separation and quantifcation of two fuoroquinolones in serum by on-line high-performance immunoaffnity chromatography. Anal. Chem. 72, 4148-4153 (2000).
72. Du LM, Lin AP, Yang YQ. Spectrofuorimetric determination of certain fuoroquinolone through charge transfer complex formation. Anal. Lett. 37, 2175-2188 (2004).
73. Jelikic-Stankov M, Stankov D, Djurdjevic P. Determination of pefoxacin in serum by time-resolved fuorimetry. Pharmazie 54, 73-74 (1999).
74. Uslu B, Topal BD, Ozkan SA. Electroanalytical investigation and determination of pefoxacin in pharmaceuticals and serum at boron-doped diamond and glassy carbon electrodes. Talanta 74, 1191-1200 (2008).
75. Radi A, Ries MAE, Kandil S. Spectroscopic and voltammetric studies of pefoxacin bound to calf thymus double-stranded DNA. Anal. Bioanal. Chem. 381, 451-455 (2005).
76. Beltagi AM. Determination of the antibiotic drug pefoxacin in bulk form, tablets and human serum using square wave cathodic adsorptive stripping voltammetry. J. Pharm. Biomed. Anal. 31, 1079-1088 (2003).
77. Gascón AR, Campo E, Oléa E et al. Pharmacokinetics and tissue distribution of intravenous pefoxacin for antibiotic prophylaxis in biliary surgery. Biopharm. Drug Depos. 23, 293-300 (2002).
78. Espinosa-Mansilla A, Muñoz de la Peña A, González Gómez D, Salinas F. Photoinduced spectrofuorimetric determination of fuoroquinolones in human urine by using three-and two-way spectroscopic data and multivariate calibration. Anal. Chim. Acta 531, 257-266 (2005).
79. Muñoz de la Peña A, Espinosa-Mansilla A, González Gómez D, Olivieri AC, Goicoechea HC. Interference-free analysis using three-way fuorescence data and the parallel factor model. Determination of fuoroquinolone antibiotics in human serum. Anal. Chem. 75, 2640-2646 (2003).
80. Espinosa-Mansilla A, Muñoz de la Peña A, Salinas F, González Gómez D. Partial least squares multicomponent fuorimetric determination of fuoroquinolones in human urine samples. Talanta 62, 853-860 (2004).
81. Vilchez JL, Ballesteros O, Taoufki J, Sánchez-Palencia G, Navalon A. Determination of the antibacterial norfoxacin in human urine and serum samples by solid-phase spectrofuorimetry. Anal. Chim. Acta 444, 279-286 (2001).
82. Feng DM, Wu HL, Ding YJ, Hu LQ, Xia AL, Yu RQ. Interference-free determination of fuoroquinolone antibiotics in plasma by using excitation-emission matrix fuorescence coupled with second-order calibration algorithms. Talanta 70, 58-62 (2006).
83. Llorent Martínez EJ, García Reyes JF, Ortega Barrales P, Molina Díaz A. Terbium-sensitized luminescence optosensor for the determination of norfoxacin in biological fuids. Anal. Chim. Acta 532, 159-164 (2005).
84. Huang KJ, Liu X, Xie WZ, Yuan HX. Electrochemical behavior and voltammetric determination of norfoxacin at glassy carbon electrode modifed with multi walled carbon nanotubes/Nafon. Colloids Surf. B Biointerfaces 64, 269-274 (2008).
85. Ghoneim MM, Radi A, Beltagi AM. Determination of norfoxacin by square wave adsorptive voltammetry on a glassy carbon electrode. J. Pharm. Biomed. Anal. 25, 205-210 (2001).
86. Galaon T, Udrescu S, Sora I, David V, Medvedovici A. High-throughput liquid chromatography method with fuorescence detection for reciprocal determination of furosemide or norfoxacin in human plasma. Biomed. Chromatogr. 21, 40-47 (2007).
87. Mascher HJ, Kikuta C. Determination of norfoxacin in human plasma and urine by high-performance liquid chromatography and fuorescence detection. J. Chromatogr. A 812, 381-385 (1998).
88. Cheng CL, Fu CH, Chou CH. Determination of norfoxacin in rat liver perfusate using capillary electrophoresis with laser-induced fuorescence detection. J. Chromatogr. B 856, 381-385 (2007).
89. Deng B, Su C, Kang Y. Determination of norfoxacin in human urine by capillary electrophoresis with electrochemiluminescence detection. Anal. Bioanal. Chem. 385, 1336-1341 (2006).
90. Liu YM, Cao JT, Tian W, Zheng YL. Determination of levofoxacin and norfoxacin by capillary electrophoresis with electrochemiluminescence detection and applications in human urine. Electrophoresis 29, 3207-3212 (2008).
91. Yang Z, Wang X, Qin W, Zhao H. Capillary electrophoresis- chemiluminescence determination of norfoxacin and prulifoxacin. Anal. Chim. Acta. 623, 231-237 (2008).
92. Okeri HA, Arhewoh IM. Analytical profle of the fuoroquinolone antibacterials. I. Ofoxacin. African J. Biotechnology 7, 670-680 (2008).
93. Al-Momani IF. Flow injection spectrophotometric determination of the antibacterial levofoxacin in tablets and human urine. Anal. Lett. 39, 741-750 (2006).
94. García MS, Albero MI, Sánchez-Pedreño C, Abuherba MS. Flow injection spectrophotometric determination of ofoxacin in pharmaceuticals and urine. Eur. J. Pharm. Biopharm. 61, 87-93 (2005).
95. Du LM, Yang YQ, Wang QM. Spectrofuorometric determination of certain quinolone through charge transfer complex formation. Anal. Chim. Acta 516, 237-243 (2004).
96. Ocaña Gonzalez JA, Callejón Mochón M, Barragán de la Rosa FJ. Spectrofuorimetric determination of levofoxacin in tablets, human urine and serum. Talanta 52, 1149-1156 (2000).
97. Ballesteros O, Vilchez JL, Navalón A. Determination of the antibacterial ofoxacin in human urine and serum samples by solid-phase spectrofuorimetry. J. Pharm. Biomed. Anal. 30, 1103-1110 (2002).
98. st derivative fuorescence spectroscopy. Talanta 53, 359-365 (2000).
99. Ocaña JA, Callejón M, Barragán FJ. Terbium-sensitized luminescence determination of levofoxacin in tablets and human urine and serum. Analyst 125, 1851-1854 (2000).
100. Shao X, Xie X, Liu Y, Song Z. Rapid determination of levofoxacin at nanogram level in pharmaceuticals and biological fuids using fow injection chemiluminescence. Curr. Anal. Chem. 2, 253-259 (2006).
101. Sun H, Li L, Chen X. Flow-injection chemiluminescence determination of ofoxacin and levofoxacin in pharmaceutical preparations and biological fuids. Anal. Sci. 22, 1145-1149 (2006).
102. Yi L, Zhao H, Chen S, Jin L, Zheng D, Wu Z. Flow-injection analysis of two fuoroquinolones by the sensitizing effect of terbium (III) on chemiluminescence of the potassium permanganate-sodium sulfte system. Talanta 61, 403-409 (2003).
103. Radi A, El-Sherif Z. Determination of levofoxacin in human urine by adsorptive square-wave anodic stripping voltammetry on a glassy carbon electrode. Talanta 58, 319-324 (2002).
104. Salem AA, Mossa HA, Barsoum BN. Quantitative determinations of levofoxacin and rifampicin in pharmaceutical and urine samples using nuclear magnetic resonance spectroscopy. Spectrochim. Acta Part A 62, 466-472 (2005).
105. Yan H, Row KH. Direct determination of ofoxacin enantiomers in human urine by ligand exchange chromatography. J. Liq. Chromatogr. 30, 1497-1511 (2007).
106. Metz P, Kohlhepp SJ, Gilbert DN. Study of different off-line sample processing procedures and the measurement of antibiotic and antiviral levels in human serum by high-performance liquid chromatography. J. Chromatogr. B 773, 159-166 (2002).
107. Gonzalez JAO, Mochon MC, de la Rosa FJB. Simultaneous determination of cefepime and the quinolones garenoxacin, moxifoxacin and levofoxacin in human urine by HPLC-UV. Microchim. Acta 151, 39-45 (2005).
108. Liang H, Kays MB, Sowinski KM. Separation of levofoxacin, ciprofoxacin, gatifoxacin, moxifoxacin, trovalfoxacin and cinoxacin by high-performance liquid chromatography: application to levofoxacin determination in human plasma. J. Chromatogr. B 772, 53-63 (2002).
109. Caufeld W V, Stewart JT. Determination of zidovudine and levofoxacin in human plasma by reversed phase HPLC and solid phase extraction. J. Liq. Chromatogr. 25, 1791-1805 (2002).
110. Djabarouti S, Boselli E, Allaouchiche B et al. Determination of levofoxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J. Chromatogr. B 799, 165-172 (2004).
111. Ishiwata Y, Son K, Itoga Y, Yasuhara M. Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofoxacin-induced seizures in rats. Biol. Pharm. Bull. 30, 745-750 (2007).
112. Chan KP, Chu KO, Lai WWK et al. Determination of ofoxacin and moxifoxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fuorescence detection. Anal. Biochem. 353, 30-36 (2006).
113. García MA, Solans C, Calvo A et al. Analysis of ofoxacin in plasma samples by high-performance liquid chromatography. Chromatographia 55, 431-434 (2002).
114. García MA, Solans C, Calvo A et al. HPLC separation and quantifcation of ofoxacin enantiomers in rabbit plasma. Application to pharmacokinetic studies. Chromatographia 56, 39-42 (2002).
115. Immanuel C, Kumar AKH. Simple and rapid high-performance liquid chromatography method for the determination of ofoxacin concentrations in plasma and urine. J. Chromatogr. B 760, 91-95 (2001).
116. Nguyen HA, Grellet J, Ba BB, Quentin C, Saux MC. Simultaneous determination of levofoxacin, gatifoxacin and moxifoxacin in serum by liquid chromatography with column switching. J. Chromatogr. B 810, 77-83 (2004).
117. Schulte S, Ackerman T, Bertram N, Sauerbruch T, Paar WD. Determination of the newer quinolones levofoxacin and moxifoxacin in plasma by high-performance liquid chromatography with fuorescence detection. J. Chromatographic Sci. 44, 205-208 (2006).
118. Cheng FC, Tsai TR, Chen YF, Hung LC, Tsai TH. Pharmacokinetic study of levofoxacin in rat blood and bile by microdialysis and high-performance liquid chromatography. J. Chromatogr. A 961, 131-136 (2002).
119. Zhou ZL, Yang M, Yu XY et al. A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofoxacin concentration and its application to bioequivalence studies. Biomed. Chromatogr. 21, 1045-1051 (2007).
120. Siewert S. Validation of a levofoxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. J. Pharm. Biomed Anal. 41, 1360-1362 (2006).
121. Bottcher S, Baum H V, Hoppe-Tichy T, Benz C, Sonntag HG. An HPLC assay and a microbiological assay to determine levofoxacin in soft tissue, bone, bile and serum. J. Pharm. Biomed. Anal. 25, 197-203 (2001).
122. Ji HY, Jeong DW, Kim YH, Kim HH, Sohn DR, Lee HS. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levofoxacin in human plasma. J. Pharm. Biomed. Anal. 41, 622-627 (2006).
123. de Boer T, Mol R, de Zeeuw RA, de Jong GJ, Ensing K. Enantioseparation of ofoxacin in urine by capillary electrokinetic chromatography using charged cyclodextrins as chiral selectors and assessment of enantioconversion. Electrophoresis 22, 1413-1418 (2001).
124. Horstkotter C, Blaschke G. Stereoselective determination of ofoxacin and its metabolites in human urine by capillary electrophoresis using laser-induced fuorescence detection. J. Chromatogr. B 754, 169-178 (2001).
125. Zhang SS, Liu HX, Wu YJ, Yu CL. On-column amperometric detection of ofoxacin and pasiniazid in urine by capillary electrophoresis with an improved fractured joint and small detection cell. Analyst 126, 441-445 (2001).
126. Xiao Y, Wang JW, Feng XG, Wang HY. Study of a fuorescence quenching mechanism of enoxacin and its determination in human serum and urine samples. J. Anal. Chem. 62, 438-443 (2007).
127. He Y, Wang HF, Yan X P. Exploring Mn-doped ZnS quantum dots for the room-temperature phosphorescence detection of enoxacin in biological fuids. Anal. Chem. 80, 3832-3837 (2008).
128. Tuncel M, Dogrukol-AK D, Senturk Z, Ozkan SA, About-Enein H. Capillary electrophoretic behavior and determination of enoxacin in pharmaceutical preparations and human serum. J. Liq. Chromatogr. 24, 2455-2467 (2001).
129. Tieli Z, Huichun Z, Linpei J. Photochemical fuorescence enhancement of the terbium-lomefoxacin complex and its application. Talanta 49, 77-82 (1999).
130. Ding F, Zhao H, Jin L, Zheng D. Study of the infuence of silver nanoparticles on the second-order scattering and the fuorescence of the complexes of Tb (III) with quinolones and determination of the quinolones. Anal. Chim. Acta 566, 136-143 (2006).
131. Nie LH, Zhao HC, Wang X et al. Determination of lomefoxacin by terbium sensitized chemiluminescence method. Anal. Bioanal. Chem. 374, 1187-1190 (2002).
132. Sun C, Lian N, Zhao H, Yi L, Jin L. Flow injection determination of lomefoxacin based on photochemically sensitized chemiluminescence. Microchim. Acta 148, 65-70 (2004).
133. Vilchez JL, Araujo L, Prieto A, Navalón A. Differential-pulse adsorptive stripping voltammetric determination of the antibacterial lomefoxacin. J. Pharm. Biomed. Anal. 26, 23-29 (2001).
134. García MA, Solans C, Calvo A, et al. Hernández E, Rey R, Bregante MA. Determination of lomefoxacin in plasma samples by HPLC with fuorescence detection. Application to pharmacokinetic studies. Chromatographia 54, 577-580 (2001).
135. Carlucci G, Mazzeo P, Vetuschi C. Development and validation of an HPLC method for determination of lomefoxacin in seminal plasma involving solid-phase extraction (SPE). J. Liq. Chromatogr. 26, 2053-2063 (2003).
136. Ocaña JA, Barragán FJ, Callejón M. Spectrofuorimetric determination of moxifoxacin in tablets, human urine and serum. Analyst 125, 2322-2325 (2000).
137. Inam R, Mercan H, Yilmaz E, Uslu B. Differential pulse polarographic determination of moxifoxacin hydrochloride in pharmaceuticals and biological fuids. Anal. Lett. 40, 529-546 (2007).
138. Erk N. Voltammetric behavior and determination of moxifoxacin in pharmaceutical products and human plasma. Anal. Bioanal. Chem. 378, 1351-1356 (2004).
139. Stass H, Dalhoff A. Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fuids by high-performance liquid chromatography with fuorescence detection using on-column focusing. J. Chromatogr. B 702, 163-174 (1997).
140. Laban-Djurdjevic A, Jelikic-Stankov M, Djurdjevic P. Optimization and validation of the direct HPLC method for the determination of moxifoxacin in plasma. J. Chromatogr. B 844, 104-111 (2006).
141. Ulu ST. High-performance liquid chromatography assay for moxifoxacin: pharmacokinetics in human plasma. J. Pharm. Biomed. Anal. 43, 320-324 (2007).
142. Lemoine T, Breilh D, Ducint D et al. Determination of moxifoxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge. J. Chromatogr. B 742, 247-254 (2000).
143. Vishwanathan K, Bartlett MG, Stewart JT. Determination of moxifoxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 30, 961-968 (2002).
144. Zimmer D, Pickard V, Czembor W, Muller C. Turbulent fow chromatography combined with tandem mass spectrometry for directly injecting raw plasma samples derived from pharmacokinetic studies. Chromatographia 52, S26-S27 (2000).
145. Guo C, Dong P, Chu Z, Wang L, Jiang W. Rapid determination of gatifoxacin in biological samples and pharmaceutical products using europium-sensitized fuorescence spectrophotometry. Luminescence 23, 7-13 (2008).
146. Zhu X, Gong A, Yu S. Fluorescence probe enhanced spectrofuorimetric method for the determination of gatifoxacin in pharmaceutical formulations and biological fuids. Spectrochim. Acta A 69, 478-482 (2008).
147. Ocaña JA, Barragán FJ, Callejón M. Spectrofuorimetric and micelle-enhanced spectrofuorimetric determination of gatifoxacin in human urine and serum. J. Pharm. Biomed. Anal. 37, 327-332 (2005).
148. Colunga-González LY, de Lerma MGG, de Torres N W, de la Luz Salazar-Cavazos M. Development of a spectrofuorimetric method for the determination of gatifoxacin in semen. Anal. Lett. 38, 2355-2364 (2005).
149. Xie X, Shao X, Yue Q, Huang C, Song Z. Ultrasensitive assay of gatifoxacin at picogram level based on its enhancing effect on the myoglobin-luminol chemiluminescence reaction. Anal. Lett. 40, 1951-1961 (2007).
150. Tasso L, Costa TD. High performance liquid chromatography for quantifcation of gatifoxacin in rat plasma following automated on-line solid phase extraction. J. Pharm. Biomed Anal. 44, 205-210 (2007).
151. Borner K, Hartwig H, Lode H. Determination of gatifoxacin in human serum and urine by HPLC. Chromatographia 52, S105-S107(2000).
152. Overholser BR, Kays MB, Sowinski KM. Determination of gatifoxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 798, 167-173 (2003).
153. Al-Dgither S, Naseeruddin A, Hammami MM. Development and validation of an HPLC method for the determination of gatifoxacin stability in human plasma. J. Pharm. Biomed. Anal. 41, 251-255 (2006).
154. Cavazos MLS, Gonzalez LYC, de Lerma GG, de Torres N W. Determination of gatifoxacin in semen by HPLC with diode-array and fuorescence detection. Chromatographia 63, 605-608 (2006).
155. Vishwanathan K, Bartlett MG, Stewart JT. Determination of gatifoxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15, 915-919 (2001).